Edition:
United States

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

13.81USD
22 May 2018
Change (% chg)

$-0.12 (-0.86%)
Prev Close
$13.93
Open
$13.90
Day's High
$13.90
Day's Low
$13.75
Volume
5,804
Avg. Vol
143,135
52-wk High
$15.80
52-wk Low
$2.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.54 -0.301
FY 2017 Dec '17 1.42 -0.903
Sep '17 0.47 -0.919
Jun '17 0.25 -1.154
Mar '17 0.00 -0.683
FY 2016 Dec '16 0.13 -0.676
Sep '16 0.16 -0.683
Jun '16 0.00 -0.754
Mar '16 0.00 -0.760
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 1.77 2.00 1.50 --
Quarter Ending Sep-18 5 1.81 2.10 1.50 --
Year Ending Dec-18 6 5.84 7.97 0.00 2.15
Year Ending Dec-19 6 9.51 26.67 0.00 6.26
Earnings (per share)
Quarter Ending Jun-18 6 -0.42 -0.29 -0.56 --
Quarter Ending Sep-18 5 -0.32 -0.29 -0.35 --
Year Ending Dec-18 6 -1.35 -1.11 -1.51 -2.22
Year Ending Dec-19 6 -1.25 -0.97 -1.83 -1.36
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 222.84 32.59
P/E High - Last 5 Yrs. -- 281.48 47.07
P/E Low - Last 5 Yrs. -- 95.47 24.59
Beta 2.33 0.75 0.79
Price to Sales (TTM) 193.06 262.06 9.01
Price to Book (MRQ) 8.21 23.14 4.24
Price to Tangible Book (MRQ) 8.10 26.27 5.79
Price to Cash Flow (TTM) -- 127.68 21.78
% Owned Institutions 87.16 10.94 2.43

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.66
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.35 4.15
Payout Ratio(TTM) -- 46.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.86 5.10
Sales (TTM) vs TTM 1 Yr. Ago 1,150.51 150.04 12.65
Sales - 5 Yr. Growth Rate -20.15 30.10 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 55.90 -158.81 33.25
EPS (TTM) vs TTM 1 Yr. Ago -17.22 -- --
EPS - 5 Yr. Growth Rate -- 46.66 8.54
Capital Spending - 5 Yr. Growth Rate 2.08 38.70 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.50
Current Ratio (MRQ) 6.95 6.54 3.56
LT Debt to Equity (MRQ) 0.00 22.23 12.86
Total Debt to Equity (MRQ) 0.00 25.74 15.83
Interest Coverage (TTM) -- -177.44 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 33.95 54.64
Gross Margin - 5 Yr. Avg. -- 54.86 52.74
EBITD Margin (TTM) -1,664.41 -- --
EBITD - 5 Yr. Avg -8,784.58 -158.47 15.84
Operating Margin (TTM) -1,686.50 -930.08 -2.34
Operating Margin - 5 Yr. Avg. -8,936.94 -171.29 11.09
Pre-Tax Margin (TTM) -1,665.11 -814.97 -0.23
Pre-Tax Margin - 5 Yr. Avg. -9,029.64 -176.85 11.29
Net Profit Margin (TTM) -1,665.11 -806.24 -3.64
Net Profit Margin - 5 Yr. Avg. -9,029.64 -176.13 7.58
Effective Tax Rate (TTM) -- 14.58 31.25
Effective Tax Rate - 5 Yr. Avg. -- 18.23 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 83,841 21,442,083 721,262,098
Net Income/Employee (TTM) -1,396,046 -1,504,037 83,813,821
Receivable Turnover (TTM) -- 16.37 5.67
Inventory Turnover (TTM) -- 2.46 3.55
Asset Turnover (TTM) 0.05 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.61 -5.46 9.98
Return on Assets - 5 Yr. Avg. -67.21 -0.52 11.07
Return on Investment (TTM) -103.66 -7.75 12.60
Return on Investment - 5 Yr. Avg. -76.07 2.72 14.34
Return on Equity (TTM) -139.38 -10.55 14.49
Return on Equity - 5 Yr. Avg. -150.99 -2.70 15.71
  1 Year 3 Year 5 Year
Sales % 671.86 -- -20.15
EPS (TTM) % -27.30 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Dicerna Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.04 21.20 88 40
13 Week 31.04 31.01 86 45
26 Week 43.46 35.54 81 84
52 Week 325.99 271.24 97 83
YTD 54.26 50.91 86 81
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 87.16%
# of Holders: 85
Total Shares Held: 46,038,771
3 Mo. Net Change: 1,603,141
# New Positions: 31
# Closed Positions: 9
# Increased Positions: 52
# Reduced Positions: 24
# Net Buyers: 28
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.